Your browser doesn't support javascript.
loading
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1.
Murray, James B; Davidson, James; Chen, Ijen; Davis, Ben; Dokurno, Pawel; Graham, Christopher J; Harris, Richard; Jordan, Allan; Matassova, Natalia; Pedder, Christopher; Ray, Stuart; Roughley, Stephen D; Smith, Julia; Walmsley, Claire; Wang, Yikang; Whitehead, Neil; Williamson, Douglas S; Casara, Patrick; Le Diguarher, Thierry; Hickman, John; Stark, Jerome; Kotschy, András; Geneste, Olivier; Hubbard, Roderick E.
Afiliação
  • Murray JB; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Davidson J; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Chen I; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Davis B; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Dokurno P; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Graham CJ; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Harris R; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Jordan A; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Matassova N; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Pedder C; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Ray S; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Roughley SD; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Smith J; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Walmsley C; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Wang Y; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Whitehead N; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Williamson DS; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
  • Casara P; Institut de Recherches Servier Oncology R&D Unit, Croissy Sur Seine 78290, France.
  • Le Diguarher T; Institut de Recherches Servier Oncology R&D Unit, Croissy Sur Seine 78290, France.
  • Hickman J; Institut de Recherches Servier Oncology R&D Unit, Croissy Sur Seine 78290, France.
  • Stark J; Institut de Recherches Servier Oncology R&D Unit, Croissy Sur Seine 78290, France.
  • Kotschy A; Servier Research Institute of Medicinal Chemistry, Budapest 1031, Hungary.
  • Geneste O; Institut de Recherches Servier Oncology R&D Unit, Croissy Sur Seine 78290, France.
  • Hubbard RE; Vernalis (R&D) Ltd., Granta Park, Abington, Cambridge CB21 6GB, U.K.
ACS Omega ; 4(5): 8892-8906, 2019 May 31.
Article em En | MEDLINE | ID: mdl-31459977
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: ACS Omega Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: ACS Omega Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido